Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01645345 · ClinicalTrials.gov registry record · NA

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

A NA study, sponsored by Alma Lasers.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT01645345: Completed NA study, sponsored by Alma Lasers.

NCT01645345 is a NA study that has completed, run by Alma Lasers. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01645345, a NA study, has completed, sponsored by Alma Lasers.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

To assess the safety and efficacy of the Pixel RF (fractional radio frequency) module in the treatment of acne scars and wrinkles.

Primary Outcome

Visual assessment of the improvement in the appearance of wrinkles and acne scars after treatment with fractionated RF.

Interventions

  • DEVICE Alma Lasers Accent RF Pixel handpiece

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2012-07
Est. Completion 2013-03
Phase NA
Alma Lasers

7 total trials

What the finished NCT01645345 record still lists

NCT01645345 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which Alma Lasers Accent RF Pixel handpiece is the first listed.

NCT01645345 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01645345 about?

NCT01645345 is a clinical study titled "Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles". To assess the safety and efficacy of the Pixel RF (fractional radio frequency) module in the treatment of acne scars and wrinkles.

What is the current status of trial NCT01645345?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2012-07. Estimated completion is 2013-03.

What interventions are being tested in trial NCT01645345?

The interventions under investigation include: Alma Lasers Accent RF Pixel handpiece (DEVICE).

Who is sponsoring clinical trial NCT01645345?

This trial is sponsored by Alma Lasers, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01645345's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01645345, the US trial registry maintained by the National Library of Medicine. NCT01645345 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.